This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
Avandia trial registration stopped
Breast cancer drug move hits shares
Avastin drug “has little impact”
Gel “halves chances of getting HIV”
Roche anxious over Avastin decision
Ecstasy “can help trauma victims”
UCB strengthens ICT department
FDA setback for weight-loss drug
Nasal spray hope for Alzheimer’s
Universal flu vaccine in prospect
Pharma cold chain criticised by expert
Avandia approved with restrictions
« Previous
1
…
53
54
55
56
57
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: